Literature DB >> 1417805

Secretory processing of the Alzheimer amyloid beta/A4 protein precursor is increased by protein phosphorylation.

S L Gillespie1, T E Golde, S G Younkin.   

Abstract

The 39-43 residue polypeptide (amyloid beta protein, beta A4) deposited as amyloid in Alzheimer's disease (AD) is derived from a set of 695-770 residue precursors referred to as the amyloid beta A4 protein precursor (beta APP). In each of the 695, 751, and 770 residue precursors, the 43 residue beta A4 is an internal peptide that begins 99 residues from the COOH-terminus of the beta APP. Each holoform is normally cleaved within the beta A4 to produce a large secreted derivative as well as a small membrane associated fragment. Neither of these derivatives can produce amyloid because neither contains the entire beta A4 peptide. In this study, we employ cells stably transfected with full length beta APP695, beta APP751, or beta APP770 expression constructs to show that phorbol ester activation of protein kinase C substantially increases the production of secreted forms from each isoform. By increasing processing of beta APP in the secretory pathway, PKC phosphorylation may help to prevent amyloid deposition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417805     DOI: 10.1016/0006-291x(92)90442-n

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  Sorting through the cell biology of Alzheimer's disease: intracellular pathways to pathogenesis.

Authors:  Scott A Small; Sam Gandy
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

Review 2.  Age-related alteration of PKC, a key enzyme in memory processes: physiological and pathological examples.

Authors:  A Pascale; S Govoni; F Battaini
Journal:  Mol Neurobiol       Date:  1998-02       Impact factor: 5.590

3.  Elevated intracellular calcium concentration increases secretory processing of the amyloid precursor protein by a tyrosine phosphorylation-dependent mechanism.

Authors:  M A Petryniak; R J Wurtman; B E Slack
Journal:  Biochem J       Date:  1996-12-15       Impact factor: 3.857

4.  Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP.

Authors:  P Marambaud; N Chevallier; K Ancolio; F Checler
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

5.  Pervanadate activation of intracellular kinases leads to tyrosine phosphorylation and shedding of syndecan-1.

Authors:  J Reiland; V L Ott; C S Lebakken; C Yeaman; J McCarthy; A C Rapraeger
Journal:  Biochem J       Date:  1996-10-01       Impact factor: 3.857

6.  Alzheimer's-specific effects of soluble beta-amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.

Authors:  A Favit; M Grimaldi; T J Nelson; D L Alkon
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

7.  Effect of protein kinase A inhibitors on the production of Abeta40 and Abeta42 by human cells expressing normal and Alzheimer's disease-linked mutated betaAPP and presenilin 1.

Authors:  P Marambaud; K Ancolio; C Alves da Costa; F Checler
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

8.  Calcium regulates processing of the Alzheimer amyloid protein precursor in a protein kinase C-independent manner.

Authors:  J D Buxbaum; A A Ruefli; C A Parker; A M Cypess; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

9.  S655 phosphorylation enhances APP secretory traffic.

Authors:  Sandra Isabel Vieira; Sandra Rebelo; Sara Catarina Domingues; Edgar F da Cruz e Silva; Odete A B da Cruz e Silva
Journal:  Mol Cell Biochem       Date:  2009-04-21       Impact factor: 3.396

10.  Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation.

Authors:  M Citron; C Vigo-Pelfrey; D B Teplow; C Miller; D Schenk; J Johnston; B Winblad; N Venizelos; L Lannfelt; D J Selkoe
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.